Search Results 841-850 of 18227 for Immunode

  1. A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS) - Mayo Clinic

    Human immunodeficiency virus, hepatitis B virus, or hepatitis C virus positivity. History of solid organ transplantation; Known or suspected allergy or ...

  2. Untitled

    Page 1.

  3. Congenital Clinical Trials - Mayo Clinic Research

    These immune deficiency diseases are thought to be rare and include: Severe combined immunodeficiency (SCID), leukocyte adhesion deficiency (LAD), X-linked ...

  4. Addition of Daratumumab to Combination of Bortezomib and Dexamethasone in Participants with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Subject is known to be seropositive for human immunodeficiency virus (HIV) or known to have hepatitis B surface antigen positivity, or known to have a history ...

  5. A Study to Learn More About Asundexian (Also Called BAY2433334) for Prevention of Ischemic Stroke in Male and Female Participants Aged 18 Years and Older Who Already Had Such a Stroke Due to a Blood Clot That Formed Outside the Heart and Travelled to the Brain, or Temporary Stroke-like Symptoms - Mayo Clinic

    Concomitant use of combined P-gp and strong CYP3A4 inhibitors e.g. human immunodeficiency virus protease inhibitors, systemically used azole antimycotic ...

  6. Mayo Clinic Laboratories.

  7. Selinexor in Advanced Liposarcoma - Clinical Trials

    Known human immunodeficiency virus (HIV) infection. Any medical condition, such as an uncontrolled infection or uncontrolled diabetes mellitus (Type 2) ...

  8. Clinical Trials - Tesevatinib in Subjects With ADPKD

    Known to be positive for the human immunodeficiency virus or hepatitis B or C, as indicated by a positive test at screening. Known to be immunocompromised ...

  9. Diphtheria and tetanus vaccine (intramuscular route) - Mayo Clinic

    Immunodeficiency disorder (low blood counts for white cells or platelets) or; Weakened immune system—May not work as well in patients with these conditions ...

  10. My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors - Mayo Clinic

    Positive human immunodeficiency virus (HIV) test, active hepatitis B virus (HBV) infection, active hepatitis C virus (HCV) infection or active tuberculosis ...